THIS STORY HAS BEEN FORMATTED FOR EASY PRINTING

AMA calls for total drug-trial disclosure

Registry aims to keep firms from hiding negative results

By Raja Mishra
Globe Staff / June 16, 2004

E-mail this article

Invalid E-mail address
Invalid E-mail address

Sending your article

Your article has been sent.

  • E-mail|
  • Print|
  • Reprints|
  • |
Text size +

Seeking to prevent drug companies from suppressing research with negative outcomes, the nation's preeminent physicians group yesterday called on the federal government to create a public registry of clinical trials that would ensure the results of all medical experiments would see the light of day. (Full Article: 488 Words)

This article is available in our archives:

Globe Subscribers

FREE for subscribers

Subscribers to the Boston Globe get unlimited access to our archives.

Not a subscriber?

Non-Subscribers

Purchase an electronic copy of the full article. Learn More

  • $4.95 1 Article
  • $9.95 4 Articles
  • $99.95 Unlimited